)
Camp4 Therapeutics (CAMP) investor relations material
Camp4 Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of three Class II Directors for a three-year term ending at the 2029 annual meeting, with nominees Steven Holtzman, Murray Stewart, and Richard Young recommended for election.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Approval of an amendment to the 2024 Equity Incentive Plan is proposed.
Proxies are authorized to vote on other business that may arise during the meeting or any adjournment.
Board of directors and corporate governance
Board recommends all director nominees for election to serve until the 2029 annual meeting.
Executive compensation and say-on-pay
Amendment to the 2024 Equity Incentive Plan is up for shareholder approval.
- Annual meeting to vote on director elections, auditor ratification, and equity plan amendment.CAMP
Proxy filing23 Apr 2026 - First-in-class ASO therapy for SYNGAP1 epilepsy set for pediatric clinical trial this year.CAMP
25th Annual Needham Virtual Healthcare Conference13 Apr 2026 - Biotech IPO targets rare genetic diseases with RNA platform, but faces high risk and funding needs.CAMP
Registration filing1 Apr 2026 - IPO aims to fund RNA-based therapies for rare genetic diseases, but faces high financial risk.CAMP
Registration filing1 Apr 2026 - Biotech IPO seeks $66.7M to advance RNA therapeutics for rare genetic diseases.CAMP
Registration filing1 Apr 2026 - Annual meeting to elect directors, ratify auditor, and review governance, compensation, and ESG.CAMP
Proxy filing1 Apr 2026 - Vote on director elections and auditor ratification at the June 2025 annual meeting.CAMP
Proxy filing1 Apr 2026 - Signed exclusive GSK deal for ASO therapeutics: $17.5M upfront, up to $440M milestones, royalties.CAMP
Q4 20251 Apr 2026 - Biotech launches $100M at-the-market stock offering to fund R&D, with Leerink Partners as agent.CAMP
Registration filing1 Apr 2026
Next Camp4 Therapeutics earnings date
Next Camp4 Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)